• Inicio
  • Login
  • Comunidades & Colecciones
Ver ítem 
  •   Repositorio Universidad Simón Bolívar
  • Producción científica
  • Artículos
  • Ver ítem
  •   Repositorio Universidad Simón Bolívar
  • Producción científica
  • Artículos
  • Ver ítem
Repositorio de la Universidad Simón Bolívar.

Evaluation of Tacrolimus Combined With Corticosteroids vs Modified Ponticelli Regimen as Treatments for Refractory Primary Membranous Nephropathy

Thumbnail
Ver/
PDF (188.9Kb)
Fecha
2018-11
Autor
Navarro-Quiroz, Elkin
Aroca-Martinez, Gustavo
Domínguez-Vargas, Alex
Alonso-López, María José
Alvarado-Echeverría, Rebeca
Navarro-Quiroz, Roberto
Silva-Díaz, Diana
Gomez Escorcia, Lorena
González-Tórres, Henry J.
Metadatos
Mostrar el registro completo del ítem

Resumen

Objective: To evaluate the immunosuppressive treatment response to modified Ponticelli regimen (MPR) and oral corticosteroid (OC) plus tacrolimus (TAC) in patients with primary membranous nephropathy (PMN). Methods: Retrospective cohort analytical study. Adults patients (>18 years old) with diagnosis of refractory PMN (>50% increase in serum creatinine or a level >1.5mg/dl or proteinuria refractory to 6 months of supportive treatment), proved by renal biopsy and immunofluorescence between 2008 and 2016 from the Nephropathy Registry of Colombia (NEFRORED©) were included. Immunosuppressive treatment response was evaluated from baseline to 6 months after the start of therapy. Results: 128 patients with PMN were included, of which 74 (57%) were female. The most frequent syndromic diagnosis was nephrotic syndrome 90 (70%), followed by asymptomatic urinary disorders 31 (25%). Chronic kidney disease manifested concomitantly in 7 (5%) patients. At the end of 6 months, 86 (67%) cases achieved some degree of remission: 23 (18%) complete response (CR) and 63 (49%) cases with partial response (PR), while 42 (33%) cases did not achieved remission. In the TAC+OC group, CR and PR were seen in 14 (20%) and 33 (47%) patients, respectively; and 9 (16%) and 30 (51%) patients in the MPR group, respectively. No statistically significant differences were found when comparing the immunosuppressive treatment response rate with both treatment groups (p > 0.05). Conclusions: In the PMN, both immunosuppressive treatments (TAC+OC vs MPR) are comparable. We suggest a clinical follow-up of the anti-PLA2R/THSD7A titres at 6/12 months to be correlated with renal function in subsequent studies.
Enlace para referencia:
http://hdl.handle.net/20.500.12442/2346
Enlace al recurso externo:
https://doi.org/10.5539/gjhs.v10n12p63

Compartir:

Impacto

Colecciones
  • Artículos [1325]

Listar

Todo DSpaceComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasProgramasSedesEsta colecciónPor fecha de publicaciónAutoresTítulosMateriasProgramasSedes

Mi cuenta

AccederRegistro

La Universidad

Bienvenida del Rector

Historia

Sala General

Direccionamiento Estrategico

Rendicion de Cuentas

Historia Gráfica

Vicerrectorías

Estatuto Corporativo

Proyecto Educativo Institucional

Reglamento Interno de Trabajo

Reglamento de Profesores

Reglamento Estudiantil

Política de privaciodad de datos personales

La Comunidad

Aspirantes

Estudiantes

Egresados

Profesores y Administrativos

Trabaje con Nosotros

Pagos en Línea

Enlaces de Interes

Lenguas Extranjeras

Teatro Jose Consuegra Higgins

Centro de Documentos

Servicios Externos

CESU

PQRS

Sede Barranquilla

SEDE PRINCIPAL

Carrera 59 No. 59-65

PBX +57 (5)344 4333

Fax +57 (5)368 2892

SEDE POSGRADOS

Carrera 54 No. 64-222

PBX +57 (5)344 3116

Fax +57 (5)349 3040

Programas Extendidos en Cúcuta

Av 3 No. 13-34 La Playa

PBX +57 (7)582 7070

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca